Article info

Download PDFPDF

1054 Blood-based detection of circulating dickkopf-1 as a prognostic biomarker in ovarian cancer patients
Free

Authors

  • P Wimberger Technische Universität Dresden, Department of Gynecology and Obstetrics, Dresden, Germany National Center for Tumor Diseases, Partner site Dresden (NCT), Dresden, Germany PubMed articlesGoogle scholar articles
  • DM Klotz Technische Universität Dresden, Department of Gynecology and Obstetrics, Dresden, Germany National Center for Tumor Diseases, Partner site Dresden (NCT), Dresden, Germany PubMed articlesGoogle scholar articles
  • T Link Technische Universität Dresden, Department of Gynecology and Obstetrics, Dresden, Germany National Center for Tumor Diseases, Partner site Dresden (NCT), Dresden, Germany PubMed articlesGoogle scholar articles
  • M Goeckenjan Technische Universität Dresden, Department of Gynecology and Obstetrics, Dresden, Germany National Center for Tumor Diseases, Partner site Dresden (NCT), Dresden, Germany PubMed articlesGoogle scholar articles
  • N Jaschke Technische Universität Dresden, Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III PubMed articlesGoogle scholar articles
  • LC Hofbauer Technische Universität Dresden, Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III PubMed articlesGoogle scholar articles
  • A Göbel Technische Universität Dresden, Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III PubMed articlesGoogle scholar articles
  • TD Rachner Technische Universität Dresden, Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III PubMed articlesGoogle scholar articles
  • JD Kuhlmann Technische Universität Dresden, Department of Gynecology and Obstetrics, Dresden, Germany National Center for Tumor Diseases, Partner site Dresden (NCT), Dresden, Germany PubMed articlesGoogle scholar articles

Citation

Wimberger P, Klotz D, Link T, et al
1054 Blood-based detection of circulating dickkopf-1 as a prognostic biomarker in ovarian cancer patients

Publication history

  • First published October 12, 2021.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.